| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/20/2010 | CA2489855C Sustained-release tramadol formulations with 24-hour clinical efficacy |
| 07/20/2010 | CA2448798C Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 07/20/2010 | CA2431982C Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
| 07/20/2010 | CA2425820C Convection-enhanced delivery of aav vectors |
| 07/20/2010 | CA2411831C Pharmaceutical compositions comprising cannabidiol derivatives |
| 07/20/2010 | CA2197235C Adenovirus comprising a gene coding for glutathion peroxidase |
| 07/16/2010 | WO2009086634A1 Fertilized egg isolate and use thereof |
| 07/16/2010 | CA2749333A1 Fertilized egg isolate and uses thereof |
| 07/15/2010 | WO2010081115A1 Pro-neurogenic compounds |
| 07/15/2010 | WO2010081034A2 Fluorine containing compounds and methods of use thereof |
| 07/15/2010 | WO2010080977A2 Oral sustained release antidepressant formulation |
| 07/15/2010 | WO2010080970A2 Oral enteric antidepressant formulation |
| 07/15/2010 | WO2010080757A2 Combinations with an alpha-4beta-2 nicotinic agonist |
| 07/15/2010 | WO2010080603A2 Method of treatment of aggression |
| 07/15/2010 | WO2010080452A2 siRNA COMPOUNDS AND METHODS OF USE THEREOF |
| 07/15/2010 | WO2010080357A1 Serotonin 5-ht2b receptor inhibitors |
| 07/15/2010 | WO2010080306A1 Purine compounds |
| 07/15/2010 | WO2010079668A1 Olefin compound |
| 07/15/2010 | WO2010079255A1 Use of inverse antagonists and/or agonists of cb1 receptors for preparing drugs to increase motor neurone excitability |
| 07/15/2010 | WO2010079241A1 Use of antagonists and/or inverse agonists of cb1 receptors for the preparation of drugs that increase motor neuron excitability |
| 07/15/2010 | WO2010079239A1 Novel thiazoles derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors |
| 07/15/2010 | WO2010079238A1 Heterotricyclic compounds as positive allosteric modulators of metabotropic glutamate receptors |
| 07/15/2010 | WO2010079045A2 New salts |
| 07/15/2010 | WO2010078833A1 Modified sodium-montmorillonite, preparing method and uses thereof |
| 07/15/2010 | WO2010078659A1 Compositions and methods for nutritional prevention and treatment of alzheimer's-associated conditions |
| 07/15/2010 | WO2010053655A3 Therapeutic methods with withaferin a and analogs |
| 07/15/2010 | WO2010042759A3 Gaba conjugates and methods of use thereof |
| 07/15/2010 | WO2010039647A3 Selective inhibitors of c-jun n-terminal kinases |
| 07/15/2010 | WO2010017626A8 Compositions comprising terpene compounds for treating negative sensory phenomena |
| 07/15/2010 | WO2010013254A3 Withania somnifera plant extract and method of preparation thereof |
| 07/15/2010 | WO2010008735A3 Solid states of o-desmethylvenlaf axine salts |
| 07/15/2010 | WO2010001167A3 Preparation of 3-pyrrole substituted 2-indolinone derivatives |
| 07/15/2010 | WO2009098051A8 Aryl sulfonamides as effective analgesics |
| 07/15/2010 | US20100179304 Somatostatin-Dopamine Chimeric analogs |
| 07/15/2010 | US20100179221 Fluorine-substituted amphetamines and amphetamine derivatives and use thereof |
| 07/15/2010 | US20100179217 Therapeutic compounds |
| 07/15/2010 | US20100179215 Doxepin isomers and isomeric mixtures and methods of using the same to treat sleep disorders |
| 07/15/2010 | US20100179214 Doxepin trans isomers and isomeric mixtures and methods of using the same to treat sleep disorders |
| 07/15/2010 | US20100179211 Disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission |
| 07/15/2010 | US20100179203 Novel pyrazole derivatives useful as potassium channel modulators |
| 07/15/2010 | US20100179202 Orally disintegrating composition of zolmitriptan |
| 07/15/2010 | US20100179201 Novel thiazole-based compound and inhibitor of t-type calcium channel containing the same |
| 07/15/2010 | US20100179199 Ethanamine Compounds and Methods of Using the Same 545 |
| 07/15/2010 | US20100179193 AMPA Receptor Antagonists and Zonisamide for Neuropathic Pain |
| 07/15/2010 | US20100179188 Nitroxide radical as treatment for neurodegeneration |
| 07/15/2010 | US20100179187 Indolone compounds useful to treat cognitive impairment |
| 07/15/2010 | US20100179183 Pharmaceutical compositions and methods for relieving pain and treating central nervous system disorders |
| 07/15/2010 | US20100179176 V3 antagonists for the treatment or prevention of chronic pain |
| 07/15/2010 | US20100179171 Pharmacological Treatment of Parkinson's Disease |
| 07/15/2010 | US20100179167 Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids |
| 07/15/2010 | US20100179166 Carboxamide heterocyclic cgrp receptor antagonists |
| 07/15/2010 | US20100179158 Inhibitors of cyclic amp phosphodiesterases |
| 07/15/2010 | US20100179154 6-CYCLOAMINO-3-(PYRID-4-YL)IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF |
| 07/15/2010 | US20100179153 Bicyclic S1P Receptor Modulators |
| 07/15/2010 | US20100179143 Naphthyridine, derivatives as p13 kinase inhibitors |
| 07/15/2010 | US20100179141 Novel jnk inhibitors |
| 07/15/2010 | US20100179140 Indenoisoquinolinone analogs and methods of use thereof |
| 07/15/2010 | US20100179139 Pyrrolopyridine compounds, process for their preparation, and their use as medicaments |
| 07/15/2010 | US20100179136 N-amino tetrahydrothiazine derivatives, method of manufacture and use |
| 07/15/2010 | US20100179130 Use of piperine and derivatives thereof for the therapy of neurological conditions |
| 07/15/2010 | US20100179127 Pyrimidine derivatives |
| 07/15/2010 | US20100179126 Thiolactams and uses thereof |
| 07/15/2010 | US20100179114 S-Isomer of 2- piperidine and Other Dermal Anesthetic Agents |
| 07/15/2010 | US20100179109 Renin inhibitors |
| 07/15/2010 | US20100179107 N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids |
| 07/15/2010 | US20100179106 Mitochondrial compositions and uses thereof |
| 07/15/2010 | US20100179103 Curcumin cyclodextrin combination for preventing or treating various diseases |
| 07/15/2010 | US20100179095 Use of folates for producing a preparation suitable for preventing and treating inflammation and diseases associated with inflammation, especially for influencing the inflammation markers crp and saa |
| 07/15/2010 | US20100178371 Composition for supressing appetite, improving tone and mood, with a natural antidepressant activity and with an antiasthenic effect |
| 07/15/2010 | US20100178362 Chromium complexes for improvement of memory and cognitive function |
| 07/15/2010 | US20100178353 Quick dissolve compositions and tablets based thereon |
| 07/15/2010 | US20100178349 Pharmaceutical formulation for the production of rapidly disintegrating tablets |
| 07/15/2010 | US20100178347 Method of treating traumatic brain injury |
| 07/15/2010 | US20100178342 Solid Pharmaceutical Preparation |
| 07/15/2010 | US20100178333 Sustained release dosage form of phenothiazine derivatives containing channelizer |
| 07/15/2010 | US20100178327 Active ingredient of a medicinal agent, a medicinal agent, a pharmaceutical composition and method for treating dementia syndrome patients |
| 07/15/2010 | US20100178307 Transdermal anti-dementia active agent formulations and methods for using the same |
| 07/15/2010 | US20100178294 Macrocyclic beta-secretase inhibitors |
| 07/15/2010 | US20100178293 Use of antibodies against the cd52 antigen for the treatment of neurological disorders, particularly transmissible spongiform encephalopathy and alzheimer's disease |
| 07/15/2010 | US20100178289 THERAPEUTIC USE OF IgG AS A NEUROPROTECTIVE AGENT |
| 07/15/2010 | US20100178282 Compounds and methods for the diagnosis and treatment of amyloid associated diseases |
| 07/15/2010 | US20100178277 Methods and compositions for stimulating cells |
| 07/15/2010 | US20100178246 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting psma |
| 07/15/2010 | DE202004021723U1 Medizinische Verwendung von Hemmern von Glutaminyl- und Glutamatcyclasen Medical use of inhibitors of glutaminyl and Glutamatcyclasen |
| 07/15/2010 | CA2749315A1 Fluorine containing compounds and methods of use thereof |
| 07/15/2010 | CA2748843A1 Heterotricyclic compounds as positive allosteric modulators of metabotropic glutamate receptors |
| 07/15/2010 | CA2748813A1 Pro-neurogenic compounds |
| 07/15/2010 | CA2746943A1 Serotonin 5-ht2b receptor inhibitors |
| 07/15/2010 | CA2746740A1 Purine compounds |
| 07/15/2010 | CA2746509A1 Method of treatment of aggression |
| 07/14/2010 | EP2206772A2 Method of collecting placental stem cells |
| 07/14/2010 | EP2206720A1 Albumin fusion proteins |
| 07/14/2010 | EP2206511A1 Protein a compositions and methods of use |
| 07/14/2010 | EP2206498A1 Mixed ORL1/[mu] agonists for treating pain |
| 07/14/2010 | EP2205633A1 New antibodies specific of the -amyloid peptides and their uses as diagnostic agents or drugs |
| 07/14/2010 | EP2205631A2 Humanized antibody |
| 07/14/2010 | EP2205596A1 (3-hydroxy-4-amino-butan-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for treating |
| 07/14/2010 | EP2205594A1 1,3,5-trisubstituted triazole derivative |
| 07/14/2010 | EP2205588A2 Oxypiperidine derivatives as histamine receptor antagonists |
| 07/14/2010 | EP2205587A2 Novel compounds |